File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.

TitleEstrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
Authors
Issue Date1994
PublisherChinese Medical Association. The Journal's web site is located at http://www.cmj.org/
Citation
Chinese Medical Journal, 1994, v. 107 n. 9, p. 648-652 How to Cite?
AbstractEstrogen and progesterone receptors (ER, PR) were measured in 21 specimens of cervical cancer and in 17 specimens of normal cervix by monoclonal enzyme immunoassay (EIA). In normal cervix, 88.2% of specimens were ER-positive ( > 15 fmol/mg protein), 74.5% were PR-positive ( > 15 fmol/mg protein) and 74.5% were both ER- and PR-positive. In cervical cancer, 66.7% were ER-positive, 42.9% were PR-positive and 38.1% were both ER- and PR- positive. There was no significant difference in ER status between the normal cervix and cervical cancer (P > 0.05), but PR status and levels in normal cervix were significantly higher than those in cervical carcinoma (P < 0.05). ER levels in squamous cell carcinoma was not correlated to the tumor stage, histologic grade and menopausal status. PR levels in premenopausal patients with squamous cell carcinoma were significantly higher than those in postmenopausal patients (P < 0.01). Adenocarcinoma of the cervix contained significantly more ER and PR than squamous cell carcinoma (P < 0.01, P < 0.05). In addition, serum E2 level was also assayed in 21 patients with cervical cancer. There was significant difference in E2 levels between the premenopausal and postmenopausal patients (P < 0.01). Patients were stratified according to E2 levels, a significant difference in PR levels and in the ratio of PR/ER was noted (P < 0.05, P < 0.01).
Persistent Identifierhttp://hdl.handle.net/10722/173207
ISSN
2015 Impact Factor: 0.957
2015 SCImago Journal Rankings: 0.428

 

DC FieldValueLanguage
dc.contributor.authorShen, Ken_US
dc.contributor.authorYueng, Wen_US
dc.contributor.authorNgan, Hen_US
dc.date.accessioned2012-10-30T06:28:31Z-
dc.date.available2012-10-30T06:28:31Z-
dc.date.issued1994en_US
dc.identifier.citationChinese Medical Journal, 1994, v. 107 n. 9, p. 648-652en_US
dc.identifier.issn0366-6999en_US
dc.identifier.urihttp://hdl.handle.net/10722/173207-
dc.description.abstractEstrogen and progesterone receptors (ER, PR) were measured in 21 specimens of cervical cancer and in 17 specimens of normal cervix by monoclonal enzyme immunoassay (EIA). In normal cervix, 88.2% of specimens were ER-positive ( > 15 fmol/mg protein), 74.5% were PR-positive ( > 15 fmol/mg protein) and 74.5% were both ER- and PR-positive. In cervical cancer, 66.7% were ER-positive, 42.9% were PR-positive and 38.1% were both ER- and PR- positive. There was no significant difference in ER status between the normal cervix and cervical cancer (P > 0.05), but PR status and levels in normal cervix were significantly higher than those in cervical carcinoma (P < 0.05). ER levels in squamous cell carcinoma was not correlated to the tumor stage, histologic grade and menopausal status. PR levels in premenopausal patients with squamous cell carcinoma were significantly higher than those in postmenopausal patients (P < 0.01). Adenocarcinoma of the cervix contained significantly more ER and PR than squamous cell carcinoma (P < 0.01, P < 0.05). In addition, serum E2 level was also assayed in 21 patients with cervical cancer. There was significant difference in E2 levels between the premenopausal and postmenopausal patients (P < 0.01). Patients were stratified according to E2 levels, a significant difference in PR levels and in the ratio of PR/ER was noted (P < 0.05, P < 0.01).en_US
dc.languageengen_US
dc.publisherChinese Medical Association. The Journal's web site is located at http://www.cmj.org/en_US
dc.relation.ispartofChinese Medical Journalen_US
dc.subject.meshAdenocarcinoma - Chemistryen_US
dc.subject.meshCarcinoma, Squamous Cell - Chemistryen_US
dc.subject.meshCervix Uteri - Chemistryen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPremenopauseen_US
dc.subject.meshReceptors, Estrogen - Analysisen_US
dc.subject.meshReceptors, Progesterone - Analysisen_US
dc.subject.meshUterine Cervical Neoplasms - Chemistryen_US
dc.titleEstrogen and progesterone receptors in normal cervix and primary cervical carcinoma.en_US
dc.typeArticleen_US
dc.identifier.emailNgan, H:hysngan@hkucc.hku.hken_US
dc.identifier.authorityNgan, H=rp00346en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.pmid7805454-
dc.identifier.scopuseid_2-s2.0-0028508762en_US
dc.identifier.volume107en_US
dc.identifier.issue9en_US
dc.identifier.spage648en_US
dc.identifier.epage652en_US
dc.publisher.placeChinaen_US
dc.identifier.scopusauthoridShen, K=7201458163en_US
dc.identifier.scopusauthoridYueng, W=6505886107en_US
dc.identifier.scopusauthoridNgan, H=34571944100en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats